Androgen Receptor Targeted Therapy + Radiotherapy in Metastatic Castration Resistant Prostate Cancer

Androgen Receptor Targeted Therapy + Radiotherapy in Metastatic Castration Resistant Prostate Cancer

ObjectivesTo investigate whether radiotherapy as metastasis-directed therapy (MDT) on oligo-progressive sites in metastatic castration-resistant prostate cancer (mCRPC) patients during treatment with androgen receptor-targeted therapy (ARTT) may lead to control resistant lesions, prolonging ARTT. We...

Full description

Bibliographic Details
Main Authors: Maria Massaro, Giuseppe Facondo, Gianluca Vullo, Anna Maria Aschelter, Alessandro Rossi, Vitaliana De Sanctis, Paolo Marchetti, Mattia Falchetto Osti, Maurizio Valeriani
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Oncology
Subjects:
oligo-progressive castration-resistant prostate cancer
androgen receptor targeted therapy
metastasis-directed radiation therapy
conformal radiotherapy
stereotactic body radiotherapy (SBRT)
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.695136/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.695136/full

Similar Items